Clinical trial Recruiting at 2 sites Observational Ages 60 and up

Measuring how hearing devices change social engagement in older adults with hearing loss

Official title: New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

Run by University of Southern California · NCT06781749 · Data updated 2026-11-12

This project will try hearing devices to see if they change social activity, thinking, and brain signals in adults aged 60 and older with hearing loss.

More Hearing Loss, Bilateral (Causes Other Than Tumors) trials

Quick facts

Study typeObservational
Ages60 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Southern California
Academic / other
Locations2 sites (Los Angeles, California and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2030
Registry record updatedMay 11, 2026
Trial IDNCT06781749 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English- or Spanish-speaking adults aged 60 or older who either have normal hearing or have bilateral hearing loss and either do or do not currently use hearing aids.

Probably not a fit

People younger than 60, those unable to complete questionnaires in English or Spanish, or those with hearing loss caused by tumors or only one-sided hearing loss are unlikely to qualify or benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares three groups: older adults with normal hearing, those with bilateral hearing loss who do not use hearing aids, and those already using hearing aids. Participants complete about 60 minutes of questionnaires about background, health, hearing, and social activity, plus cognitive testing, and some will have EEG recordings to measure brain activity. For people who begin using hearing devices, researchers will compare social, cognitive, and EEG measures before and after device use and compare results across the three groups. The team will test whether changes in social interaction explain any changes in thinking and whether EEG patterns shift with hearing-device use.

Why it matters

Potential benefit: If successful, the results could help clinicians and patients understand whether hearing devices improve social life and thinking in older adults and inform hearing-care decisions.

How similar studies have gone: Prior research has shown mixed but promising evidence that treating hearing loss with hearing aids can improve social engagement and cognitive outcomes, though findings are not yet definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>= 60 years
* English or Spanish speaking
* Group 1- older adults with normal hearing defined as speech frequency PTA \<25dB HL in bilateral ears
* Group 2- older adults with bilateral hearing loss who are not using hearing aids
* Group 3- older adults with bilateral hearing loss, who are currently using hearing aids

Exclusion Criteria:

* Age \<60 years
* Unable to complete questionnaires in English or Spanish

Where it's running

  • Los Angeles General Medical Center
    Los Angeles, California, United States
    Recruiting
  • University of Southern California
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.